A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

29 Nov 2018

2018 Access to Medicine Index finds that pharmaceutical companies are deepening their focus on Africa

Amsterdam, the Netherlands, 29 November 2018 – The new Access to Medicine Index notes increasing interest from multinational pharmaceutical companies...

20 Nov 2018

Now online: 6th Access to Medicine Index

The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the po...

20 Nov 2018

Coming up: Index briefings to inform policy on global health

The Access to Medicine Foundation will be holding a series of policy and technical briefings with government representatives from Germany, Japan...

20 Nov 2018

New online: you choose which companies to compare side by side

We are publishing the new Access to Medicine Index on a new website. Our goal was to make it easier for you to find what you are looking for and to co...

05 Nov 2018

Goldman Sachs & UBS to co-host investor launches of 2018 Access to Medicine Index

On Thursday 22 November, Goldman Sachs will co-host the London investor event about the 2018 Index together with the Access to Medicine Foundation. Tw...

22 Oct 2018

2018 Access to Medicine Index launches on 20 November

The Access to Medicine Foundation will publish the 6th Access to Medicine Index on Tuesday 20 November 2018. The latest report will show what 20 of th...

27 Sep 2018

Foundation hosts high-level meeting in Mumbai

On 5 September 2018, the Access to Medicine Foundation convened a group of executives from the pharmaceutical industry in India and globally, for a da...

14 Sep 2018

First Japanese asset owner signs the Foundation’s investor statement

The Dai-ichi Life Insurance Company is the latest asset owner and the first Japanese life insurance company to sign the investor statement of the Acce...

28 Aug 2018

Foundation to convene high-level meeting in Mumbai on access to medicine and AMR

The Access to Medicine Foundation will be visiting Mumbai, India, next week for a one-day meeting with pharmaceutical companies to discuss strategies...

03 Aug 2018

New paper explains expanded Index focus on global health R&D

A new article published in Health Research Policy and Systems sets out how the 2018 Access to Medicine Index will analyse pharmaceutical companies R&D...

02 Aug 2018

Data analysis gathers pace for 2018 Access to Medicine Index

The 2018 Access to Medicine Index will be the 6th ranking of the world’s largest pharmaceutical companies on their access-to-medicine performances. We...

13 Jul 2018

Index added to new online toolbox for impact investors

The Access to Medicine Index and AMR Benchmark have been added to Navigating Impact, a new online resource centre developed specifically for impact in...

27 Jun 2018

Experts gather to discuss proposals for 2020 Antimicrobial Resistance Benchmark

On 2 July 2018, the Foundation's Expert Committee will meet in Amsterdam to discuss methodology proposals for the next Antimicrobial Resistance B...

08 Jun 2018

Access to Medicine Index gains first Japanese signatory investor

Sumitomo Mitsui Trust Holdings is the latest investor to publicly endorse the Access to Medicine Index, becoming the 68th signatory to the Index inves...

31 May 2018

Access to Medicine Foundation makes case for fixing the antibiotic market

Today, the Access to Medicine Foundation warns that antibiotic supply chains are on the brink of collapse, putting basic healthcare at risk, in a new...

18 May 2018

Foundation to co-host events at WHO World Health Assembly

Jayasree K. Iyer, Executive Director, will speak at two events being co-hosted by the Foundation at the 71st WHO World Health Assembly (WHA). On Tuesd...

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |